Properties of a new anti-IL-17 antibody

Nature Reviews Rheumatology, Published online: 07 September 2023; doi:10.1038/s41584-023-01028-xA monoclonal antibody targeting a peptide that replicates the proinflammatory properties of IL-17 has shown potent activity and an acceptable profile of adverse effects in pre-clinical studies.

Source: Nature Reviews Rheumatology - September 7, 2023 Category: Rheumatology Authors: Robert Phillips Source Type: research